Skip to content

Clinical trials

Recruiting Phase 1/2 Gastrointestinal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 1/2 Status: Recruiting Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20191
20222
20234
20241
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Revolution Medicines, Inc.3
DualityBio Inc.2
BigHat Biosciences, Inc.1
Binhui Biopharmaceutical Co., Ltd.1
GlaxoSmithKline1
Marengo Therapeutics, Inc.1
Mayo Clinic1
National Cancer Institute (NCI)1
National University Hospital, Singapore1
Northwestern University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms17
Pancreatic Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Colonic Neoplasms6
Colorectal Neoplasms6
Neoplasms6
Lung Neoplasms5
Neoplasm Metastasis5
Stomach Neoplasms5
Endometrial Neoplasms4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.